Skip to main content
. Author manuscript; available in PMC: 2020 Aug 1.
Published in final edited form as: Angiogenesis. 2019 Jan 14;22(3):369–382. doi: 10.1007/s10456-019-09662-4

Fig. 6.

Fig. 6.

Aflibercept, but not anti-Scg3 mAb, retards body weight gain in neonatal mice. Anti-Scg3 ML78.2 mAb or aflibercept was i.p. injected to mice at P3, 5, 7, 9, 11 and 13. a Representative images of mouse size. b Body weight of aflibercept-treated mice. c Body weight of anti-Scg3 mAb-treated mice. n=3 mice, ±SEM, one-way ANOVA test.